Shareholders meeting

Vimta Labs Limited Registered Office 142, IDA Phase II, Cheriapally Hyderabad-500 051,Telangana, India T: •91 40 27264141 F: ~91 40 27263657 Driven byQuality. Inspired byScience. VLL\SE\023\2026-27 Date: 25.06.2026 B S E Limited, National Stock Exchange ofIndia Limited, P Towers, Dais!Street, “Exchange Plaza”, Bandra, Kurla Complex, Mumbai 400001. Bandra (E),Mumbai 400051. Scrip Code: 524394 Trading Symbol: VIMTALABS Dear Sir/Madam, Sub: Proceeding of36” Annual General Meeting (AGM) held on Thursday, 25”June 2026. Ref: Regulation 30, Schedule III, Part A (13) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. With reference to our letter dated 01”June 2026, informing you about the 36th Annual General Meeting (e-AGM) of the members ofthe Company to be held through Video Conference (VC)/ OtherAudio-Visual Means (OAVM) on 25”June 2026. In this regard,we wish to inform that the e-AGM was held today, i.e., onThursday, 25dIJune 2026 through VC, in compliance with various Circulars issued by Ministry of Corporate Affairs and other applicable provisions ofthe Companies Act, 2013 and Circulars issued b3 the Securities and Exchange Board ofIndia. In accordance with Regulation 30 ofthe SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the summary of the proceeding of the 36” AGM of the Company is enclosed as an Annexure. This is for yourinformation and records Thankingyou, ForVIMTA LABS LIMITED Sujani Vasireddi Company Secretaty End: Summary ofproceedings ofthe 36thAGM Plot No. 5, LifeSciences Facility, NeovantageScience& Technology Park Private Limited, Shamirpet, GenomeValley, Turkapally Medchal-Malkajgiri, Hyderabad-500101, Telangana, India. T: +91 406740 4040 E: mdofflce@vimta.com URL : www.vimta.com GIN: L24110TG1990PLC011977 Vimta Labs Limited a Registered Office 142, IDA Phase II, Cherlapally Hyderabad-500 051,Telangana, India T: +91 4027264141 F: ~91 40 27263657 Driven byQuality. Inspired by Science. SUMMARY OF PROCEEDINGS OF THE 36th ANNUAL GENERAL MEETING The Annual General Meeting ~AGM~ of the Members of \ imta abs Limited (“the 36th Company”) was held onThursday, 25”june 2026 at 10.00 am. throu’h XideoConferencing (VC) in compliance with circulars issued by Ministry of Corporate Affairs and SEBI circulars, which permits companies toholdAGM throughVideo Conferencing (VC) orOtherAudioVisualMeans (OAVM) and in conipliance with the provisions of the Companies Act, 2013 (“Act”), and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). Directors Present through Video Conference: Dr. S.P. Vasireddi Chairman Executive Director Independent Director & Chairman ofAudit Committee Shri. G Purnachandra Rao and Stakeholder Relationship Committee Smt. Y Prameela Rani Independent Director Independent Director & Nomination and Remuneration Shn. Sanjay Dave Committee Chairman Dr. Yadagiri R Pendri Independent Director Smt. Narita Vasireddi Managing Director Shri. Harriman Vungal Executive Director Operations Shri. Satya Sreenivas Neerukonda Executive Director Invitees Present through Video Conference: Shri. Kancharla Haribabu Partner, Gattamaneni & Co. (Statutory Auditors) Shri. D Hanumanta Raju Partners, D Hanumanta Raju & Co. Smt. Razia Shaik (Secretarial Auditors) Shri. Siva Rama Krishna. Kambhampati ChiefFinancial Officer In attendance (through Video Conference): Smt. Sujani Vasireddi Company Secretary Members Present and proceedings: The Company Secretary welcomed the shareholders and directors to the Company’s 36,h AGM. After ensuring that the requisite quorum was present, the Company Secretary requested Dr. S.P. \Tasireddi, Chairman, to commence the proceedings ofthe meeting. The Company Secretary informed the members that the statutory registers such as register of Directors and Key Managerial Personnel and their shareholding (as per Section 170 of the Companies Act, 2013) and register ofContracts as per Section 189 ofthe Companies Act, 2013) are made available electronically for inspection. She then requested the Chairman to address the members. Dr. S.P. Vasireddi, Chairman chaired the meeting and commenced the proceedings through VC. Therequisite quorum beingpresent, he called theMeeting to order. He furtherinformed that since the meetingwas being held electronically, the proxy related procedures had been dispensed with. Plot No. 5, LifeSciences Facility, NeovantageScience& Technology Park Private Limited, Shamirpet, Genome Medchal-Malkajgiri, Hyderabad-500101, Telangana, India.T: ÷91 40 67404040 E: mdoffice@vimta.com URL: CIN : L24110TG1990PLC011977 Vimta Labs Limited Registered Office 142, IDA Phase II, Cherlapally Hyderabad-500 051,Telangana, India T: +91 4027264141 F: •91 4027263657 Driven byQuality. Inspired byScience. Further, the Chairman, introduced the members ofthe Board, K1%WPs, the Statutory Auditors and the Secretarial Auditor, he also informed the members that Shri G Purnachandra Rao, Director ~xho is also the Chairman of the Audit and Stakeholders Relationship Committee was also present at the e i\GM. 36th The Shareholders were informed that the copies ofAudited Financial Statements for the financial year ended 31” March 2026, Board’s Report alongwith all the annexures and Auditors report had been emailed to all the Members. The shareholders were further informed that the Company had provided the Members the facility to cast their vote electronically (remote c-voting) on all resolutions set forth in the Notice. Members who‘vere present at the ACM and had not cast their votes electronically through remote c-voting were provided an opportunity to cast their xotes through e voting during the meeting. The shareholders who had registered as speakers expressed theirviews and raised their questions and Board ofDirectors replied to the queries and provided necessary clarifications, as appropriate to the speaker shareholders concerned. 1’he following items ofthe business, as set out in the Notice of the s\GM were transacted at 36rh the Meeting: Ordinary Business: 1. To receive, consider and adopt the Audited Financial Statements of the company for the financial year ended 31” March 2026 together with the reports ofthe Board ofDirectors and the Auditors ofthe company thereon. 2. To declare a Dividend of~ 2/- per equity share for the financial year ended 31” March 2026. 3. To appoint a director in place ofMr. Harriman Vungal (DIN 00242621), Executive Director Operations, who retires by rotation and being eligible, offered himself for re-appointment as a director liable to retire by rotation. Upon reappointment, Mr. Harriman Vungal will continue to be the Executive Director Operations for the rest ofhis tenure as per the terms ofhis appointment. SDecial Business: 4. Ratification ofremuneration ofcost auditors for financial year ended 31” March 2025. 5. Ratification ofremuneration ofcost auditors for financial year ended 31” March 2026. 6. Reappointment ofDr. S P Vasireddi (DIN: 00242288) as Executive Chairman ofthe Company. The Chairman informed the Shareholders that Ms. Razia Shaik, or failing him, Mr. Mohit Kumar Goyal, Partners, M/s D. 1-lanumanta Raju & Co., Company Secretaries, Hyderabad, are appointed as the Scrutinizers for the c-voting process to be conducted in a fair and transparent manner and to report on the votingresults for the items as per the Notice of the ACM. 36th TheChairman also authori’ed theCompanySecretary on behalfoftheBoard, to declare theresults of voting within two working days of the conclusion of the AGM and the same along with scrutinizer’s report shall be submitted to the stock exchanges and the same be available on the websites ofthe Company and the Stock exchanges (NSE and BSE. The meeting concluded at 10:55 AM.(IST) with vote ofthanks. Plot No. 5, Life Sciences Facility, NeovantageScience &Technology Park Private Limited, Turkapally Medchal-Malkajgiri, Hyderabad-500 101, Telangana, India. T: ~91 40 67404040 E: m [Showing first 8,000 characters — download PDF for full document]